| Literature DB >> 34797955 |
Anna Helova1, Maricianah Onono2, Lisa L Abuogi3, Karen Hampanda4, Kevin Owuor2,5, Tobias Odwar2, Sandhya Krishna1, Gladys Odhiambo2, Thomas Odeny2,6, Janet M Turan1.
Abstract
INTRODUCTION: Community-based mentor mothers (cMMs) are women living with HIV who provide peer support to pregnant/postpartum women living with HIV (PWLWH) to enhance antiretroviral therapy (ART) adherence, retention in care and prevent perinatal transmission of HIV. The goal of this study was to explore the experiences, perceptions, mechanisms and health impact of cMMs on PWLWH in Kenya from the perspective of cMMs.Entities:
Keywords: Kenya; adherence; community-based mentor mothers; pregnant/postpartum women living with HIV; prevention of mother-to-child transmission of HIV
Mesh:
Year: 2021 PMID: 34797955 PMCID: PMC8604379 DOI: 10.1002/jia2.25843
Source DB: PubMed Journal: J Int AIDS Soc ISSN: 1758-2652 Impact factor: 5.396
Socio‐demographic and HIV‐related characteristics of study participants
| Characteristics | Community mentor mothers ( | Pregnant women living with HIV ( |
|---|---|---|
| Variables reported at study baseline: | ||
| Age (mean, SD) | 34.2 (±6.7) | 28.9±5.6 |
| Age category | ||
| <25 years | 169 (28.7%) | |
| ≥25 years | 419 (71.3%) | |
| Education | ||
| Did not complete secondary | 9 (37.5%) | Not available |
| Completed secondary educ. | 15 (62.5%) | |
| Number of living children (cMMs)/number of pregnancies (pregnant women) (mean, SD) | 2.9 (±1.3) | 3.5 (±1.7) |
| 1 | 43 (7.3%) | |
| ≥ 2 | 545 (92.7%) | |
| Weeks of pregnancy when started study | N.A. | 23.6 (±7.6) |
| ≤ 28 weeks gestational age | 439 (74.7%) | |
| > 28 weeks gestational age | 149 (25.3%) | |
| Marital status | ||
| Married | 15 (62.5%) | 545 (92.7%) |
| Not married | 9 (37.5%) | 43 (7.3%) |
| HIV at first antenatal visit | ||
| Newly positive | N.A. | 101 (17.2%) |
| Known positive | 487 (82.8%) | |
| Partner's HIV status | ||
| Positive | 14 (58.3%) | 108 (18.6%) |
| Negative | 8 (33.3%) | 23 (4.0%) |
| Unknown | 2 (8.3%) | 451 (77.5%) |
| Intervention arm | N.A. | |
| cMM | 297 (50.5%) | |
| cMM + text messaging | 291 (49.5%) | |
| Variables captured after baseline: | ||
| Total # cMM total visits (mean, SD) | N.A. | 6.2 (±1.9) |
| Visit categories | ||
| 0 | 7 (1.2%) | |
| 1 | 11 (1.9%) | |
| 2 | 13 (2.2%) | |
| 3 | 24 (4.1%) | |
| 4 | 39 (6.7%) | |
| 5 | 80 (13.8%) | |
| 6 | 108 (18.6%) | |
| 7 | 108 (18.6%) | |
| 8 | 192 (33.0%) | |
| Disclosure to male partner at baseline | N.A. | |
| Yes | 545 (92.7%) | |
| No | 43 (7.3%) | |
| Disclosure to male partner at the time of birth | N.A. | |
|
| ||
| Yes | 553 (96.3%) | |
| No | 21 (3.7%) | |
| Infant exclusive breastfeeding at 6 weeks after birth | N.A. | |
| Yes |
| |
| No | 492 (99.8%) | |
| Missing | 1 (0.2%) | |
| Mother's ART adherence at 6 weeks postpartum | N.A. | |
| Good (>95%) | 564 (97.1%) | |
| Less than good (≤95%) | 17 (2.9%) | |
| Mother's VL at 6 weeks postpartum | N.A. |
|
| Undetectable (0 copies/ml) | 295 (72.3%) | |
| Viral suppression (>0, <1000 copies/ml) | 88 (21.6%) | |
| Not virally suppressed (1000 copies/ml) | 25 (6.1%) | |
| Health facility delivery | N.A. | |
| Yes | 538 (91.5%) | |
| No | 50 (8.5%) | |
| Infant testing at 6 weeks after birth | N.A. | |
| Yes | 570 (97.9%) | |
| No | 12 (2.1%) | |
| Optimal PMTCT composite outcomea
| N.A. |
|
| Yes | 261 (69.8%) | |
| No | 80 (30.2%) |
Abbreviations: ART, antiretroviral therapy; cMM, community‐based mentor mothers; PMTCT, prevention of mother‐to‐child transmission; SD, standard deviation; VL, viral load.
Optimal composite outcome (infant testing at 6 weeks, facility delivery, good adherence and undetectable VL at 6 weeks postpartum).
Figure 1Adapted conceptual framework of community mentor mothers (cMMs) and PWLWH served, building on a Katigbak conceptual framework for the role of community health workers in facilitating patients’ adoption of health behaviours [12]. Abbreviations: ART, antiretroviral therapy; cMM, community‐based mentor mothers; PMTCT, prevention of mother‐to‐child transmission.
Univariable analyses of the association between PWLWH characteristics and uptake of select PMTCT services and health behaviours
| Factor | Mother's ART adherence at 6 weeks postpartum | Mother's undetectable VL at 6 weeks postpartum | Optimal PMTCT composite outcome | |||
|---|---|---|---|---|---|---|
| RR (95% CI) |
| RR (95% CI) |
| RR (95% CI) |
| |
| # of total cMM visits | ||||||
| ≤4 | Ref. | Ref. | Ref. | |||
| >4 | 1.02 (0.99–1.06) | 0.200 | 1.35 (0.95–1.90) | 0.091 | 1.46 (1.03–2.06) | 0.034 |
| Age at baseline | ||||||
| <25 years | Ref. | Ref. | Ref. | |||
| ≥25 years | 1.02 (0.98–1.06) | 0.298 | 1.18 (0.98–1.41) | 0.081 | 0.15 (0.97–1.36) | 0.111 |
| Gravida | ||||||
| Primigravid | Ref. | Ref. | Ref. | |||
| ≥ 2 | – | – | 0.97 (0.77–1.23) | 0.793 | 0.94 (0.74–1.19) | 0.607 |
| Weeks of pregnancy when started study | ||||||
| ≤ 28 weeks | Ref. | Ref. | Ref. | |||
| > 28 weeks | 1.01 (0.98–1.03) | 0.670 | 0.93 (0.78–1.12) | 0.470 | 0.94 (0.78–1.13) | 0.495 |
| Marital status | ||||||
| Not married | Ref. | Ref. | Ref. | |||
| Married | 1.01 (0.96–1.06) | 0.700 | 1.00 (0.87–1.15) | 0.994 | 0.96 (0.82–1.12) | 0.615 |
| HIV at first ANC visit | ||||||
| Newly positive | 0.97 (0.94–1.00) | 0.068 | 0.97 (0.76–1.23) | 0.776 | 0.98 (0.76–1.26) | 0.844 |
| Known positive | Ref. | Ref. | Ref. | |||
| Partner's HIV status | ||||||
| Positive | Ref. | Ref. | Ref. | |||
| Negative/unknown | 1.00 (0.96–1.05) | 0.919 | 1.04 (0.88–1.23) | 0.616 | 1.04 (0.88–1.22) | 0.658 |
| Intervention arm | ||||||
| Cmm | Ref. | Ref. | Ref. | |||
| cMM + text messaging | 1.01 (0.96–1.06) | 0.658 | 0.96 (0.75–1.23) | 0.757 | 0.99 (0.76–1.28) | 0.912 |
| Disclosure to male partner by the birth | ||||||
| Yes | 1.03 (0.92–1.16) | 0.581 | 1.23 (0.69–2.17) | 0.485 | 1.26 (0.64–2.49) | 0.510 |
| No | Ref. | Ref. | Ref. | |||
Abbreviations: ANC, antenatal visit; ART, antiretroviral therapy; CI, confidence interval; cMM, community‐based mentor mothers; PMTCT, prevention of mother‐to‐child transmission; PWLWH, pregnant/postpartum women living with HIV; VL, viral load.
Multivariable analyses of the association between PWLWH characteristics and uptake of select PMTCT services and health behaviours
| Factor | Mother's ART adherence at 6 weeks postpartum | Mother's undetectable VL at 6 weeks postpartum | Optimal PMTCT composite outcome | |||
|---|---|---|---|---|---|---|
| aRRa (95% CI) |
| aRR (95% CI) |
| aRR (95% CI) |
| |
| # of total cMM visits | 0.044 | |||||
| ≤4 | Ref. | 0.177 | Ref. | 0.119 | Ref. | |
| >4 | 1.02 (0.99–1.06) | 1.31 (0.93–1.83) | 1.42 (1.01–2.01) | |||
| Age at baseline | 0.093 | |||||
| <25 years | Ref. | 0.245 | Ref. | 0.056 | Ref. | |
| ≥25 years | 1.02 (0.98–1.07) | 1.18 (1.00–1.39) | 1.14 (0.98–1.33) | |||
| Weeks of pregnancy when started study | ||||||
| ≤ 28 weeks | Ref. | 0.108 | Ref. | 0.428 | Ref. | 0.511 |
| > 28 weeks | 1.02 (1.00–1.03) | 0.93 (0.77–1.12) | 0.94 (0.79–1.13) | |||
| Partner's HIV status | 0.316 | |||||
| Positive | Ref. | 0.798 | Ref. | 0.262 | Ref. | |
| Negative/unknown | 1.00 (0.97–1.04) | 1.11 (0.92–1.33) | 1.10 (0.92–1.31) | |||
Abbreviations: aRR, adjusted relative risk; ART, antiretroviral therapy; CI, confidence interval; cMM, community‐based mentor mothers; PMTCT, prevention of mother‐to‐child transmission; PWLWH, pregnant/postpartum women living with HIV; VL, viral load.
The outcomes were adjusted for weeks of pregnancy at the start of the study, given that this variable influenced the duration of time that women had available to receive the stipulated number of cMM visits.
Side‐by‐side comparison of qualitative and quantitative results showing the impact of cMMs in supporting PWLWH in completion of PMTCT continuum steps
| Themes | In‐depth interviews with cMMs ( | Quantitative data ( | |
|---|---|---|---|
| 1. | Utilization and acceptability of the cMM intervention |
Serve as role models and confidantes May be referred over the facility‐based mentor mothers due to privacy, convenience and dedicated attention |
The overall number of cMM visits achieved may indicate high acceptability of the cMM visits. Participants had, on average, 6.2 out of 8 cMM visits during pregnancy and up to 6 weeks postpartum. |
| 2. | CMM roles |
Supporting acceptance of HIV status and providing encouragement about the potential of having an HIV‐negative child Assisting with partner disclosure/communication Linking and referring women to HIV care, PMTCT and maternal and child health services Providing tangible support (development of birth plans, medication pick‐up and help with household finances) | |
| 3. | Improved PMTCT behaviours |
Improved ART adherence and retention in care Delivery at a health facility Infant HIV testing, infant adherence to ARV, immunization and safe infant feeding |
88.7% of women were retained in in the study and HIV care up to 6 weeks postpartum. Having four or more cMM visits in the peripartum period was associated with achieving optimal completion of PMTCT steps, including infant testing at 6 weeks, facility delivery, good ART adherence and undetectable VL at 6 weeks postpartum (aRR = 1.42, |
| 4. | Disclosure as a potential mechanism for the impact of cMM visits on outcomes | cMMs felt that one of the most important ways that their visits positively impacted outcomes was through assistance with male partner communication and disclosure |
96.30% of women reported having disclosed their HIV status to their male partner by the time of the delivery. Disclosure of HIV status to a male partner by the time of the birth was not significantly associated with optimal PMTCT composite outcome (RR = 1.26, |
Abbreviations: ART, antiretroviral therapy; cMM, community‐based mentor mothers; PMTCT, prevention of mother‐to‐child transmission; PWLWH, pregnant/postpartum women living with HIV; RR, relative risk; VL, viral load.